ArticleTrials2017

The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given 'as needed' in mild asthma: study protocols for two randomised controlled trials.

Paul M O'Byrne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.